These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18551403)

  • 1. Identification of COL6A1 as a differentially expressed gene in human astrocytomas.
    Fujita A; Sato JR; Festa F; Gomes LR; Oba-Shinjo SM; Marie SK; Ferreira CE; Sogayar MC
    Genet Mol Res; 2008 Apr; 7(2):371-8. PubMed ID: 18551403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACTB and SDHA Are Suitable Endogenous Reference Genes for Gene Expression Studies in Human Astrocytomas Using Quantitative RT-PCR.
    Röhn G; Koch A; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818802318. PubMed ID: 30259794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
    Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of immune defense genes in pilocytic astrocytomas.
    Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
    Neder L; Marie SK; Carlotti CG; Gabbai AA; Rosemberg S; Malheiros SM; Siqueira RP; Oba-Shinjo SM; Uno M; Aguiar PH; Miura F; Chammas R; Colli BO; Silva WA; Zago MA
    Brain Pathol; 2004 Oct; 14(4):399-405. PubMed ID: 15605987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
    van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
    Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
    Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
    Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative transcriptomics reveals similarities and differences between astrocytoma grades.
    Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B
    BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.
    Tchoghandjian A; Fernandez C; Colin C; El Ayachi I; Voutsinos-Porche B; Fina F; Scavarda D; Piercecchi-Marti MD; Intagliata D; Ouafik L; Fraslon-Vanhulle C; Figarella-Branger D
    Brain; 2009 Jun; 132(Pt 6):1523-35. PubMed ID: 19336457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression.
    Comincini S; Facoetti A; Del Vecchio I; Peoc'h K; Laplanche JL; Magrassi L; Ceroni M; Ferretti L; Nano R
    Anticancer Res; 2004; 24(3a):1507-17. PubMed ID: 15274317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
    Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
    J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms.
    Hunter S; Young A; Olson J; Brat DJ; Bowers G; Wilcox JN; Jaye D; Mendrinos S; Neish A
    J Neuropathol Exp Neurol; 2002 Mar; 61(3):275-81. PubMed ID: 11895042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of PRND gene expression profiles in astrocytomas: relationship to tumor grades of malignancy.
    Comincini S; Ferrara V; Arias A; Malovini A; Azzalin A; Ferretti L; Benericetti E; Cardarelli M; Gerosa M; Passarin MG; Turazzi S; Bellazzi R
    Oncol Rep; 2007 May; 17(5):989-96. PubMed ID: 17390034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.